• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK SECONDARY MEDICATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK SECONDARY MEDICATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2C7461
Medical Device Problem Code Unexpected Color (4055)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/05/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a clearlink secondary medication set had milky looking fluid in the drip chamber.This was discovered during priming.When the nurse back primed the line (cleansed the primary line with alcohol and allowed to dry, then connected the dry secondary line and opened secondary line clamp to allow primary fluid to backfill), the normal saline liquid came out milky.There was no patient involvement.No additional information is available.
 
Additional Manufacturer Narrative
E1: initial reporter address: (b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
H10: the actual device was discarded; however, a photograph of the sample was provided for evaluation.A visual inspection was performed to the photograph using the naked eye and and no visual defect was observed on the set.The reported milky looking fluid in the drip chamber was observed in the photos provided.Therefore, the reported condition was verified.The cause of the condition could not be determined, however, a possible cause could be after the residual alcohol was dry and then the saline solution was primed into the set, a milky color solution was produced.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK SECONDARY MEDICATION SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - SINGAPORE
2 woodlands industrial park d
singapore 73875 0
SN   738750
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key16933995
Report Number1416980-2023-02341
Device Sequence Number7375306
Product Code FPA
UDI-Device Identifier00085412049069
UDI-Public(01)00085412049069
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K203609
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 06/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number2C7461
Device Lot NumberSR22D30001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/19/2023
Supplement Date Received by Manufacturer05/30/2023
Initial Report FDA Received Date05/15/2023
Supplement Report FDA Received Date06/15/2023
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-